文献速递睡眠呼吸障碍头颈外科

阻塞性睡眠呼吸暂停患者上颌下颌前移术的转诊与接受情况

Patient Referral and Acceptance of Maxillomandibular Advancement for Obstructive Sleep Apnea.
PubMed 文献 · Laryngoscope · 2023-11-06

本研究回顾性分析了2018至2020年在本机构因不耐受持续气道正压通气而接受药物诱导睡眠内镜、并被推荐行上颌下颌前移术的阻塞性睡眠呼吸暂停患者,通过现时问卷调查评估转诊后的随访率及选择原因。159例转诊患者中77例(48%)至口腔颌面外科随访,29例(18%)接受手术,58例(36.5%)失访。未随访者主要顾虑手术侵入性(39%)和恢复时间(17%)。

要点

  • 159例转诊患者中仅77例(48%)至口腔颌面外科随访,29例(18%)接受上颌下颌前移术。
  • 未随访者顾虑手术侵入性(39%)、恢复时间(17%)或两者兼有(31%)。
  • 未接受手术者中28.6%未使用任何阻塞性睡眠呼吸暂停治疗。

核心结论

  • 转诊行上颌下颌前移术的患者中不到一半进行了随访,随访者中不到一半接受了手术。
  • 多数患者顾虑手术的侵入性和恢复过程。

研究设计与样本

  • 回顾性研究,纳入2018至2020年在本机构因阻塞性睡眠呼吸暂停且不耐受持续气道正压通气、接受药物诱导睡眠内镜后推荐行上颌下颌前移术的连续患者,共159例转诊至口腔颌面外科。
  • 通过现时联系患者并进行经机构审查委员会批准的问卷调查。

主要发现

  • 159例转诊患者中77例(48%)至口腔颌面外科随访,29例(18%)接受上颌下颌前移术,62例(40%)恢复持续气道正压通气,58例(36.5%)失访。
  • 73例(46%)完成问卷,其中37例(51%)至口腔颌面外科随访,17例(23%)接受上颌下颌前移术。
  • 未至口腔颌面外科随访者中,39%顾虑手术侵入性,17%顾虑恢复时间,31%同时顾虑两者。
  • 接受咨询者中,73%因无法耐受持续气道正压通气,14%因不适合Inspire,14%希望了解替代治疗。
  • 未接受上颌下颌前移术者中28.6%未使用阻塞性睡眠呼吸暂停治疗。

局限性

  • 证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Maxillomandibular advancement (MMA) is an effective surgical treatment for obstructive sleep apnea (OSA); however, it is unclear how many patients who are referred for MMA actually undergo surgery. This study aims to determine follow-up rates for patients referred for MMA and the reasons behind their choices. METHODS: Via retrospective review, we assessed consecutive patients with OSA intolerant to continuous positive airway pressure (CPAP) who underwent drug induced sleep endoscopy (DISE) between 2018 and 2020 at our institution. Patients recommended for MMA based on DISE and other findings were included. Patients were then contacted and administered an IRB-approved survey in present time. RESULTS: One hundred and fifty nine patients were referred to oral maxillofacial surgery (OMFS) for MMA consult. Seventy seven patients (48%) followed up with OMFS and 29 (18%) underwent MMA. Sixty two (40%) patients resumed CPAP. Fifty eight patients (36.5%) were lost to follow up. Seventy three patients (46%) completed our survey. Of those patients, 37 (51%) followed up with OMFS and 17 (23%) underwent MMA. Patients who did not follow up with OMFS cited the invasiveness of the surgery (39%), recovery time (17%), or both (31%) as reasons. Those who pursued consultation cited inability to tolerate CPAP (73%), not being a candidate for inspire (14%), and desire to learn about alternative treatments (14%) as reasons. Of those who did not undergo MMA, 28.6% are not using OSA treatment. CONCLUSION: Less than half of patients referred for MMA followed up, and less than half of those patients underwent MMA. Most patients cited concerns about the invasiveness of the surgery and recovery process. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:2964-2969, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Rodin J, Fiorella M, Crippen M, et al. Patient Referral and Acceptance of Maxillomandibular Advancement for Obstructive Sleep Apnea. Laryngoscope. 2023. PMID: 37929825. doi:10.1002/lary.31152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。